Market Intelligence Resource | October 17, 2012
FDA Approval For QbTest A Computerized ADHD Assessment/Diagnostic System
October 17, 2012
On December 3, 2012, Swedish company Qbtech announced that the U.S. Food and Drug Administration (FDA) had approved QbTest,the companys computer- based diagnostic system for attention-deficit/hyperactivity disorder (ADHD). QbTest provides provides objective and validated decision making support for diagnosis and treatment of ADHD in children, adolescents, and adults. Qbtech believes that QbTest is the first test of its kind to have been cleared by the FDA. QbTest is currently available for lease in the United States. The price varies with patient volume and processes.
Download the Report
. . .
Want To Read More? Log In Or Become A Paid Member
